Drug Type Small molecule drug |
Synonyms KU 5039 |
Target |
Mechanism AMPK agonists(AMP activated protein kinase agonists), Insulin sensitizers |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 1 | US | - | |
Insulin Resistance | Phase 1 | US | - |